Literature DB >> 7557581

Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases.

C J Healey1, R W Chapman, K A Fleming.   

Abstract

Forty two cases of confirmed hepatitis C virus (HCV) infection with available liver histology were studied. Most patients, 23 of 42 (55%) had abnormal liver function tests but 19 of 42 (45%) had persistently normal liver transaminases (mean aspartate transaminase (AST) 24.1 IU/l, mean follow up 10 months). Histological examinations in the group with normal AST activities were normal in two of 19 (11%), showed non-specific reactive hepatitis in eight of 19 (42%), chronic persistent hepatitis in six of 19 (31%), and chronic active hepatitis in three of 19 (16%). Twenty three of 42 (55%) had either persistently or temporary raised liver transaminases (mean AST 96.2 IU/l, mean follow up 16 months). Histological examinations in this second group with abnormal liver biochemistry showed reactive hepatitis in five of 23 (22%), chronic persistent hepatitis in six of 23 (26%), chronic active hepatitis in 10 of 23 (43%), and cirrhosis in two (9%). Average alcohol intake was significantly higher in the group within abnormal liver function (17.8 v 6.4 units, p = 0.01). Although serious pathology was more frequent in the abnormal transaminase group, significant liver pathology (chronic persistent hepatitis or chronic active hepatitis) was found in nine of 19 (47%) of cases with repeatedly normal transaminases. Liver biopsy is advised in all cases of chronic hepatitis C infection to accurately assess both the degree of fibrosis and the current activity of the disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557581      PMCID: PMC1382731          DOI: 10.1136/gut.37.2.274

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Chronic hepatitis C virus infection--a disease in waiting?

Authors:  A J Czaja
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

2.  High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.

Authors:  J I Esteban; J C López-Talavera; J Genescà; P Madoz; L Viladomiu; E Muñiz; C Martin-Vega; M Rosell; H Allende; X Vidal
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

3.  Asymptomatic hepatitis C infection. Be cautious with liver biopsy.

Authors:  R Valori; J Christie
Journal:  BMJ       Date:  1994-05-07

4.  Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

Authors:  A Alberti; G Morsica; L Chemello; D Cavalletto; F Noventa; P Pontisso; A Ruol
Journal:  Lancet       Date:  1992-09-19       Impact factor: 79.321

5.  Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up.

Authors:  M Yousuf; Y Nakano; E Tanaka; T Sodeyama; K Kiyosawa
Journal:  Scand J Gastroenterol       Date:  1992-09       Impact factor: 2.423

6.  Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis.

Authors:  A M Di Bisceglie; Z D Goodman; K G Ishak; J H Hoofnagle; J J Melpolder; H J Alter
Journal:  Hepatology       Date:  1991-12       Impact factor: 17.425

7.  Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group.

Authors:  L B Seeff; Z Buskell-Bales; E C Wright; S J Durako; H J Alter; F L Iber; F B Hollinger; G Gitnick; R G Knodell; R P Perrillo
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

8.  Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis.

Authors:  F Tremolada; C Casarin; A Alberti; C Drago; A Tagger; M L Ribero; G Realdi
Journal:  J Hepatol       Date:  1992-11       Impact factor: 25.083

9.  Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and polyposis coli.

Authors:  C S Potten; M Kellett; D A Rew; S A Roberts
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

10.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

View more
  12 in total

1.  Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment.

Authors:  G Montalto; L Giannitrapani; M Soresi; L Virruso; D D Martino; R Gambino; A Carroccio; M Cervello
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

2.  Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection.

Authors:  S Anderson; C L Nevins; L K Green; H El-Zimaity; B S Anand
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 3.  [Therapy of hepatitis C].

Authors:  D M Alscher; J C Bode
Journal:  Med Klin (Munich)       Date:  1997-03-15

Review 4.  Histopathology and detection of hepatitis C virus in liver.

Authors:  P J Scheuer; K Krawczynski; A P Dhillon
Journal:  Springer Semin Immunopathol       Date:  1997

5.  Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III.

Authors:  F Serejo; A Costa; A G Oliveira; F Ramalho; A Batista; M C De Moura
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

6.  Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure.

Authors:  H Eguchi; K Umeshita; M Sakon; H Nagano; Y Ito; S I Kishimoto; K Dono; S Nakamori; T Takeda; M Gotoh; K Wakasa; N Matsuura; M Monden
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

7.  Risky alcohol use and serum aminotransferase levels in HIV-infected adults with and without hepatitis C.

Authors:  Judith I Tsui; Debbie M Cheng; Howard Libman; Carly Bridden; Richard Saitz; Jeffrey H Samet
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

8.  Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thin-needle biopsy.

Authors:  Daniela Petz; Sabine Klauck; Friedrich-Wilhelm Röhl; Peter Malfertheiner; Albert Roessner; Christoph Röcken
Journal:  Virchows Arch       Date:  2003-01-28       Impact factor: 4.064

9.  AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.

Authors:  D W Reedy; A T Loo; R A Levine
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

10.  Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.

Authors:  A H Mohsen; P J Easterbrook; C Taylor; B Portmann; R Kulasegaram; S Murad; M Wiselka; S Norris
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.